LIVE

Serial Number

88819345

Owner

Vanda Pharmaceuticals Inc.

Attorney

Jayme M. Torelli

First Use Date

Dec 1, 2020

Filing Date

Mar 3, 2020

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

HETLIOZ (TASIMELTEON) CAPSULES Trademark

Serial Number: 88819345 • Registration: 6815599

HETLIOZ (TASIMELTEON) CAPSULES is a trademark filed by Vanda Pharmaceuticals Inc. on March 3, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Vanda Pharmaceuticals Inc. (104 trademarks)

Suite 300
Rockville, MD 20850

Entity Type: 03

Legal Representation

Attorney of Record

Jayme M. Torelli

173 trademarks filed View all →

Trademark Details

Filing Date

March 3, 2020

Registration Date

August 9, 2022

First Use Anywhere

December 1, 2020

First Use in Commerce

December 1, 2020

Published for Opposition

August 17, 2021

Goods & Services

Pharmaceutical preparations, containing tasimelteon, for use in the treatment of Smith-Magenis Syndrome; Pharmaceutical preparations, containing tasimelteon, for use in the treatment of sleep disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 9, 2022 NRCC

REGISTERED-PRINCIPAL REGISTER

Aug 9, 2022 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jul 7, 2022 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 6, 2022 CNPR

ASSIGNED TO EXAMINER

Jun 9, 2022 DOCK

STATEMENT OF USE PROCESSING COMPLETE

Apr 21, 2022 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 21, 2022 AITU

USE AMENDMENT FILED

Apr 11, 2022 IUAF

TEAS STATEMENT OF USE RECEIVED

Apr 11, 2022 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 12, 2021 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 17, 2021 NPUB

PUBLISHED FOR OPPOSITION

Aug 17, 2021 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 28, 2021 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 14, 2021 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 3, 2021 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 2, 2021 CRFA

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Jul 2, 2021 ERFR

NOTIFICATION OF FINAL REFUSAL EMAILED

Feb 22, 2021 GNFN

FINAL REFUSAL E-MAILED

Feb 22, 2021 GNFR

FINAL REFUSAL WRITTEN

Feb 22, 2021 CNFR

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 1, 2021 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 1, 2021 CRFA

ASSIGNED TO LIE

Jan 29, 2021 ALIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 20, 2020 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 26, 2020 GNRN

NON-FINAL ACTION E-MAILED

May 26, 2020 GNRT

NON-FINAL ACTION WRITTEN

May 26, 2020 CNRT

ASSIGNED TO EXAMINER

May 21, 2020 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Mar 10, 2020 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 9, 2020 NWOS

NEW APPLICATION ENTERED

Mar 6, 2020 NWAP

Related Trademarks

More from this Owner

NEREUS (TRADIPITANT)

NEREUS (TRADIPITANT) CAPSULES

Serial #99839209

NEREUS 85MG (TRADIPITANT) CAPSULES

DELOSRX

QUIMILZA

More in Same Class

CAVI GUARD